Evidence map›Paper›PMID 24695618›Full record

ArticlePloS one2014

The mechanisms underlying α-amanitin resistance in Drosophila melanogaster: a microarray analysis.

Chelsea L Mitchell, Michael C Saul, Liang Lei, Hairong Wei, Thomas Werner

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Phenoconversion andHepatology forum · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Chelsea L MitchellDepartment of Biological Sciences, Michigan Technological University, Houghton, Michigan, United States of America.
Michael C SaulDepartment of Zoology, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Liang LeiSchool of Forest Resources and Environmental Science, Michigan Technological University, Houghton, Michigan, United States of America.
Hairong WeiSchool of Forest Resources and Environmental Science, Michigan Technological University, Houghton, Michigan, United States of America.
Thomas WernerDepartment of Biological Sciences, Michigan Technological University, Houghton, Michigan, United States of America.
Michigan Technological University · USMichigan United · USUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid evolution of toxin resistance in animals has important consequences for the ecology of species and our economy. Pesticide resistance in insects has been a subject of intensive study; however, very little is known about how Drosophila species became resistant to natural toxins with ecological relevance, such as α-amanitin that is produced in deadly poisonous mushrooms. Here we performed a microarray study to elucidate the genes, chromosomal loci, molecular functions, biological processes, and cellular components that contribute to the α-amanitin resistance phenotype in Drosophila melanogaster. We suggest that toxin entry blockage through the cuticle, phase I and II detoxification, sequestration in lipid particles, and proteolytic cleavage of α-amanitin contribute in concert to this quantitative trait. We speculate that the resistance to mushroom toxins in D. melanogaster and perhaps in mycophagous Drosophila species has evolved as cross-resistance to pesticides, other xenobiotic substances, or environmental stress factors.

Indexed as

Alpha-AmanitinAnimalsBiochemical PhenomenaBiological EvolutionDrosophila melanogasterDrug ResistanceLipidsMetabolic Detoxication, Phase IMetabolic Detoxication, Phase IIMicroarray AnalysisPhenotypeAlpha-AmanitinLipids

Identifiers

PMID24695618
PMCPMC3973583
OpenAlexW2037251347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.